SlideShare a Scribd company logo
1 of 20
Download to read offline
Qualified Person
and
Mi D i tiMinor Deviations
P. Iamartino – EIPG Italian Delegate
Malta, 18th April 2008
Overview
• EMEA Reflection PaperEMEA Reflection Paper
• EIPG Working Group
• Comments of Interested Parties
• Conclusions• Conclusions
EMEA Reflection Paperp
• It was published on March 2006p
• It deals with minor deviations from the
details described in the MA
• It is recognized that “ from time to time• It is recognized that from time to time
minor deviations from the details set out in
h l dthe MA application do occur”
EMEA Reflection Paperp
• The issue is whether a QP may certify and
l h b hrelease such batches
• No harmonised approach exists in the EU• No harmonised approach exists in the EU
• The proposal deals with the one-off type ofThe proposal deals with the one off type of
deviations
• Recurrent deviations are outside the scope
of the EMEA proposalof the EMEA proposal
EMEA Reflection Paperp
A simple and pragmatic approach is proposedA simple and pragmatic approach is proposed,
based on:
1. responsibility of QP to make decisions
2. principles of quality risk management
3. documentation made available on request
EMEA Reflection Paperp
Application criteria:
• deviation is minor, one-off, unplanned
d i ti t ff ti f t ffi• deviation not affecting safety or efficacy
• API and finished products specs not involvedp p
• to assess the need of an on-going stability test
• QRM to be integrated into the QA system
• all deviations to be reviewed as part of the AQR
EMEA Reflection Paperp
• To minimise the occurrence of deviations it• To minimise the occurrence of deviations, it
is requested to remove unnecessary details
from MA application
• Any deviation which may affect the safety or• Any deviation which may affect the safety or
efficacy or compromises the overall quality
must result in a QP decision not to release the
batch
EMEA Reflection Paperp
• A feedback was requested to all interested
parties
• Amendment to Annex 16 was pointed outAmendment to Annex 16 was pointed out
• In February 2007 a new request of reply, on ay q p y,
structured form, was issued
• A meeting with industry representatives and
associations was planned by September 2007p y p
EIPG Working Groupg p
• QP responsibilities and duties is part of
G i lEIPG strategic plan
• A Working Group was set up in Prague• A Working Group was set up in Prague
(2007 G.A.) to prepare a reply to EMEA
• All delegations were invited to give their
comments and contributionscomments and contributions
• An official EIPG document was submittedAn official EIPG document was submitted
to EMEA on September 2007
EIPG Working Groupg p
Innovative Issues
• promotion of quality risk management
i i lprinciples
• increase of QP discretion power and• increase of QP discretion power and
extension of responsibilities
• benefit in time response and in flexibility
from Regulatory Bodiesfrom Regulatory Bodies
EIPG Working Groupg p
Critical Issues
• a cultural change is required for the
i l t ti f QRM i i limplementation of QRM principles
• reducing level of details in MA seemsreducing level of details in MA seems
difficult to be applied to existing dossiers
• more flexible approach is required for
dealing with recurrent deviationsdealing with recurrent deviations
EIPG Working GroupEIPG Working Group
Key PointsKey Points
• incorporation into EU GMPsp
(Annex 16 and other sections of GMPs)
• QP responsibilities and duties• QP responsibilities and duties
• QP reliance on the quality system
• extension of the principles to IMPs
Comments of Interested Parties
Meeting held in London on 26 Sept 2007 with:
APIC/CEFICAPIC/CEFIC
EFPIA
EGAEGA
EIPG
EQPA
EVM
IFAH-EU
ISPEISPE
PDA
PPTAPPTA
AESGP
Comments of Interested Parties
• Most of Interested Parties presentedMost of Interested Parties presented
detailed comments and suggestions
• EFPIA took the lead of the discussion
• A common position was agreed
A presentation as made to EMEA• A presentation was made to EMEA
Comments of Interested Parties
• Reflection Paper generally welcomedReflection Paper generally welcomed
• Most companies not aware of the
Reflection Paper
• Proposal of EMEA not accepted byProposal of EMEA not accepted by
Authorities in some Member States
St t d i l l f d t il• Strong support on reducing level of details
in MA dossiers
Comments of Interested Parties
QP discretion should be broadened
to include:
t d i tirecurrent deviations
minor changes, pending approval of a filed
variation
OOS deviations for non critical attributes
deviations from IMP dossier
not impacting safety or efficacy
Comments of Interested Parties
• To extend the scope to any minor deviation
(starting and packaging materials specs IPCs)(starting and packaging materials specs, IPCs),
provided that safety and efficacy are met
• To clarify that the QP involved in release of
intermediate stage products may adopt the sameg p y p
principles
T l if th t it i t l t• To clarify that it is not always necessary to
perform a formal risk assessment, but an
i f l l i i t blinformal analysis is acceptable
Comments of Interested Parties
• The Reflection Paper is too limited as itThe Reflection Paper is too limited, as it
does not allow for the full qualification and
t bilit f th QP i b t h laccountability of the QP in batch release
decision
• Interested Parties ready to actively
contrib te to re ision of Anne 16 andcontribute to revision of Annex 16 and
GMPs to harmonise the QP role
Comments of Interested Parties
All comments presented to EMEAAll comments presented to EMEA
Principles of the Reflection Paper accepted
by all Member States
Harmonisation on QP role expectedHarmonisation on QP role expected
Agreement on the Annex 16 revision
Further discussion required before
implementationp
Conclusions
1. EIPG was officially recognised among the1. EIPG was officially recognised among the
European professional bodies
2. Broadening of QP discretion power is the
key issue for the next futurey
3. QP qualification and professional
development is part of EIPG strategic plan

More Related Content

What's hot

INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxPrachiSharma575050
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countriesJAYA PRAKASH VELUCHURI
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEjagrutivasava
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European UnionBindu Kshtriya
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESvasanthi chodavarapu
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigationsArete-Zoe, LLC
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union ShantanuThakre3
 
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxAartiVats5
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionDoninder Hooda
 
China Excipients Regulation Overview
China Excipients Regulation OverviewChina Excipients Regulation Overview
China Excipients Regulation OverviewMilliporeSigma
 
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, DefinitionsMedical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, DefinitionsArete-Zoe, LLC
 
Neutraceuticals GMP
Neutraceuticals GMPNeutraceuticals GMP
Neutraceuticals GMPSanthiNori1
 
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Australia
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESChandra Mohan
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
 

What's hot (20)

INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICE
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Union
 
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATESQUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
 
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
 
UDI
UDIUDI
UDI
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
 
China Excipients Regulation Overview
China Excipients Regulation OverviewChina Excipients Regulation Overview
China Excipients Regulation Overview
 
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, DefinitionsMedical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
 
Neutraceuticals GMP
Neutraceuticals GMPNeutraceuticals GMP
Neutraceuticals GMP
 
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting   professor pirouziFda guidance for pharmaceutical post marketing reporting   professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGES
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
 

Similar to The Qualified Person and Minor Deviations

CCXG Forum, March 2021, Simon Fellermeyer
CCXG Forum, March 2021, Simon FellermeyerCCXG Forum, March 2021, Simon Fellermeyer
CCXG Forum, March 2021, Simon FellermeyerOECD Environment
 
ISO 14064_2018.pdf
ISO 14064_2018.pdfISO 14064_2018.pdf
ISO 14064_2018.pdfMau Tau
 
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016EEP Mekong
 
EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...
 EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H... EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...
EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...Environmental Protection Agency, Ireland
 
Presentation Updating the Manufacturing Principles
Presentation Updating the Manufacturing Principles Presentation Updating the Manufacturing Principles
Presentation Updating the Manufacturing Principles TGA Australia
 
Webinar on Environmental Footprint Screening study
Webinar on Environmental Footprint Screening studyWebinar on Environmental Footprint Screening study
Webinar on Environmental Footprint Screening studyMarisa Vieira
 
A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...OECD Environment
 
UNEP E.CLARK - 15° Convegno Europeo
UNEP E.CLARK - 15° Convegno EuropeoUNEP E.CLARK - 15° Convegno Europeo
UNEP E.CLARK - 15° Convegno EuropeoCentro Studi Galileo
 
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016EEP Mekong
 
Module 2rev
Module 2revModule 2rev
Module 2revcomesa15
 
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...Ethical Sector
 
ETIP PV conference: 'Photovoltaics: centre-stage in the power system
ETIP PV conference: 'Photovoltaics: centre-stage in the power systemETIP PV conference: 'Photovoltaics: centre-stage in the power system
ETIP PV conference: 'Photovoltaics: centre-stage in the power systemCluster TWEED
 
AGS Members' Day 2015 - Business Practice Presentation
AGS Members' Day 2015 - Business Practice PresentationAGS Members' Day 2015 - Business Practice Presentation
AGS Members' Day 2015 - Business Practice PresentationForumCourt
 
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...TGA Australia
 
2020 GRESB Real Estate & Infrastructure Results - Nordics
2020 GRESB Real Estate & Infrastructure Results - Nordics2020 GRESB Real Estate & Infrastructure Results - Nordics
2020 GRESB Real Estate & Infrastructure Results - NordicsGRESB
 

Similar to The Qualified Person and Minor Deviations (20)

CCXG Forum, March 2021, Simon Fellermeyer
CCXG Forum, March 2021, Simon FellermeyerCCXG Forum, March 2021, Simon Fellermeyer
CCXG Forum, March 2021, Simon Fellermeyer
 
ISO 14064_2018.pdf
ISO 14064_2018.pdfISO 14064_2018.pdf
ISO 14064_2018.pdf
 
Timo Ligi and Erik Akse, regulatory impact assessment in Montenegro, Budva 18...
Timo Ligi and Erik Akse, regulatory impact assessment in Montenegro, Budva 18...Timo Ligi and Erik Akse, regulatory impact assessment in Montenegro, Budva 18...
Timo Ligi and Erik Akse, regulatory impact assessment in Montenegro, Budva 18...
 
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016
EEP Mekong: 6th Call for Proposals Meeting in Yangon, 1 July 2016
 
EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...
 EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H... EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...
EPA H2020 SC5 Info Day: Involving stakeholders to ask the right questions, H...
 
Presentation Updating the Manufacturing Principles
Presentation Updating the Manufacturing Principles Presentation Updating the Manufacturing Principles
Presentation Updating the Manufacturing Principles
 
Webinar on Environmental Footprint Screening study
Webinar on Environmental Footprint Screening studyWebinar on Environmental Footprint Screening study
Webinar on Environmental Footprint Screening study
 
A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...
 
UNEP E.CLARK - 15° Convegno Europeo
UNEP E.CLARK - 15° Convegno EuropeoUNEP E.CLARK - 15° Convegno Europeo
UNEP E.CLARK - 15° Convegno Europeo
 
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016
EEP Mekong: 6th Call for Proposals Meeting in Vientiane, 22 June 2016
 
Module 2rev
Module 2revModule 2rev
Module 2rev
 
IEA DSM Task XXIV webinar
IEA DSM Task XXIV webinarIEA DSM Task XXIV webinar
IEA DSM Task XXIV webinar
 
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...
Sector Specific EIA Guidelines for Oil and Gas Activities in Myanmar - Initia...
 
Presentation, Karen Hill, SIGMA, Paris, 4 December 2015_English
Presentation, Karen Hill, SIGMA, Paris, 4 December 2015_EnglishPresentation, Karen Hill, SIGMA, Paris, 4 December 2015_English
Presentation, Karen Hill, SIGMA, Paris, 4 December 2015_English
 
Audits of Less Complex Entities Update
Audits of Less Complex Entities UpdateAudits of Less Complex Entities Update
Audits of Less Complex Entities Update
 
ETIP PV conference: 'Photovoltaics: centre-stage in the power system
ETIP PV conference: 'Photovoltaics: centre-stage in the power systemETIP PV conference: 'Photovoltaics: centre-stage in the power system
ETIP PV conference: 'Photovoltaics: centre-stage in the power system
 
ISPC observations on the CRP pre-proposals & what needs to be done
ISPC observations on the CRP pre-proposals & what needs to be doneISPC observations on the CRP pre-proposals & what needs to be done
ISPC observations on the CRP pre-proposals & what needs to be done
 
AGS Members' Day 2015 - Business Practice Presentation
AGS Members' Day 2015 - Business Practice PresentationAGS Members' Day 2015 - Business Practice Presentation
AGS Members' Day 2015 - Business Practice Presentation
 
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...
 
2020 GRESB Real Estate & Infrastructure Results - Nordics
2020 GRESB Real Estate & Infrastructure Results - Nordics2020 GRESB Real Estate & Infrastructure Results - Nordics
2020 GRESB Real Estate & Infrastructure Results - Nordics
 

More from European Industrial Pharmacists Group

PHAR-IN: Competences for industrial pharmacy practice in biotechnology
PHAR-IN: Competences for industrial pharmacy practice in biotechnologyPHAR-IN: Competences for industrial pharmacy practice in biotechnology
PHAR-IN: Competences for industrial pharmacy practice in biotechnologyEuropean Industrial Pharmacists Group
 
Future supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachFuture supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachEuropean Industrial Pharmacists Group
 
CMAC: A national research centre in continuous manufacturing and crystallisation
CMAC: A national research centre in continuous manufacturing and crystallisationCMAC: A national research centre in continuous manufacturing and crystallisation
CMAC: A national research centre in continuous manufacturing and crystallisationEuropean Industrial Pharmacists Group
 
Development of Biopharmaceuticals: Structure and Formulation Considerations
Development of Biopharmaceuticals: Structure and Formulation ConsiderationsDevelopment of Biopharmaceuticals: Structure and Formulation Considerations
Development of Biopharmaceuticals: Structure and Formulation ConsiderationsEuropean Industrial Pharmacists Group
 

More from European Industrial Pharmacists Group (20)

Update and status of the Falsified Medicines Directive (FMD)
Update and status of the Falsified Medicines Directive (FMD)Update and status of the Falsified Medicines Directive (FMD)
Update and status of the Falsified Medicines Directive (FMD)
 
Shortages of medicines originating from manufacturing
Shortages of medicines originating from manufacturingShortages of medicines originating from manufacturing
Shortages of medicines originating from manufacturing
 
A paradigm shift in clinical trials
A paradigm shift in clinical trialsA paradigm shift in clinical trials
A paradigm shift in clinical trials
 
Introduzione al tema serializzazione e tracciabilità
Introduzione al tema serializzazione e tracciabilitàIntroduzione al tema serializzazione e tracciabilità
Introduzione al tema serializzazione e tracciabilità
 
Making the case for personalised medicine
Making the case for personalised medicineMaking the case for personalised medicine
Making the case for personalised medicine
 
Precision medicines – delivering to patients
Precision medicines – delivering to patientsPrecision medicines – delivering to patients
Precision medicines – delivering to patients
 
Verification of Medicinal Products in Europe: An EIPG Perspective
Verification of Medicinal Products in Europe: An EIPG PerspectiveVerification of Medicinal Products in Europe: An EIPG Perspective
Verification of Medicinal Products in Europe: An EIPG Perspective
 
Formulation of Protein Based Drugs
Formulation of Protein Based DrugsFormulation of Protein Based Drugs
Formulation of Protein Based Drugs
 
PHAR-IN: Competences for industrial pharmacy practice in biotechnology
PHAR-IN: Competences for industrial pharmacy practice in biotechnologyPHAR-IN: Competences for industrial pharmacy practice in biotechnology
PHAR-IN: Competences for industrial pharmacy practice in biotechnology
 
Cancer Research UK Formulation Unit
Cancer Research UK Formulation UnitCancer Research UK Formulation Unit
Cancer Research UK Formulation Unit
 
Future supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approachFuture supply chains for the pharmaceutical industry – a collaborative approach
Future supply chains for the pharmaceutical industry – a collaborative approach
 
New Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines ConsortiumNew Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines Consortium
 
CMAC: A national research centre in continuous manufacturing and crystallisation
CMAC: A national research centre in continuous manufacturing and crystallisationCMAC: A national research centre in continuous manufacturing and crystallisation
CMAC: A national research centre in continuous manufacturing and crystallisation
 
A View on Drug Shortages from EIPG
A View on Drug Shortages from EIPGA View on Drug Shortages from EIPG
A View on Drug Shortages from EIPG
 
Development of Biopharmaceuticals: Structure and Formulation Considerations
Development of Biopharmaceuticals: Structure and Formulation ConsiderationsDevelopment of Biopharmaceuticals: Structure and Formulation Considerations
Development of Biopharmaceuticals: Structure and Formulation Considerations
 
Pharma 2014: Rework, Renaissance or Ragnarök?
Pharma 2014: Rework, Renaissance or Ragnarök?Pharma 2014: Rework, Renaissance or Ragnarök?
Pharma 2014: Rework, Renaissance or Ragnarök?
 
Industrial Pharmacist Vision of Clinical Trials
Industrial Pharmacist Vision of Clinical TrialsIndustrial Pharmacist Vision of Clinical Trials
Industrial Pharmacist Vision of Clinical Trials
 
Implementation of Annex 13 of the EU GMP Guide
Implementation of Annex 13 of the EU GMP GuideImplementation of Annex 13 of the EU GMP Guide
Implementation of Annex 13 of the EU GMP Guide
 
Current Landscape for Safety Reporting in Clinical Trials
Current Landscape for Safety Reporting in Clinical TrialsCurrent Landscape for Safety Reporting in Clinical Trials
Current Landscape for Safety Reporting in Clinical Trials
 
Regulatory Control of Clinical Trials
Regulatory Control of Clinical TrialsRegulatory Control of Clinical Trials
Regulatory Control of Clinical Trials
 

Recently uploaded

Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...Angel
 
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...Sheetaleventcompany
 
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...Sheetaleventcompany
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfTrustlife
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Sheetaleventcompany
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxSwetaba Besh
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppjimmihoslasi
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunSheetaleventcompany
 
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...GENUINE ESCORT AGENCY
 
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...dishamehta3332
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...Sheetaleventcompany
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationMedicoseAcademics
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsMedicoseAcademics
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Sheetaleventcompany
 
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...Dipal Arora
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableJanvi Singh
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana GuptaLifecare Centre
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Sheetaleventcompany
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...Sheetaleventcompany
 

Recently uploaded (20)

Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
 
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
 
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
 
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
 
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
 
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
 

The Qualified Person and Minor Deviations

  • 1. Qualified Person and Mi D i tiMinor Deviations P. Iamartino – EIPG Italian Delegate Malta, 18th April 2008
  • 2. Overview • EMEA Reflection PaperEMEA Reflection Paper • EIPG Working Group • Comments of Interested Parties • Conclusions• Conclusions
  • 3. EMEA Reflection Paperp • It was published on March 2006p • It deals with minor deviations from the details described in the MA • It is recognized that “ from time to time• It is recognized that from time to time minor deviations from the details set out in h l dthe MA application do occur”
  • 4. EMEA Reflection Paperp • The issue is whether a QP may certify and l h b hrelease such batches • No harmonised approach exists in the EU• No harmonised approach exists in the EU • The proposal deals with the one-off type ofThe proposal deals with the one off type of deviations • Recurrent deviations are outside the scope of the EMEA proposalof the EMEA proposal
  • 5. EMEA Reflection Paperp A simple and pragmatic approach is proposedA simple and pragmatic approach is proposed, based on: 1. responsibility of QP to make decisions 2. principles of quality risk management 3. documentation made available on request
  • 6. EMEA Reflection Paperp Application criteria: • deviation is minor, one-off, unplanned d i ti t ff ti f t ffi• deviation not affecting safety or efficacy • API and finished products specs not involvedp p • to assess the need of an on-going stability test • QRM to be integrated into the QA system • all deviations to be reviewed as part of the AQR
  • 7. EMEA Reflection Paperp • To minimise the occurrence of deviations it• To minimise the occurrence of deviations, it is requested to remove unnecessary details from MA application • Any deviation which may affect the safety or• Any deviation which may affect the safety or efficacy or compromises the overall quality must result in a QP decision not to release the batch
  • 8. EMEA Reflection Paperp • A feedback was requested to all interested parties • Amendment to Annex 16 was pointed outAmendment to Annex 16 was pointed out • In February 2007 a new request of reply, on ay q p y, structured form, was issued • A meeting with industry representatives and associations was planned by September 2007p y p
  • 9. EIPG Working Groupg p • QP responsibilities and duties is part of G i lEIPG strategic plan • A Working Group was set up in Prague• A Working Group was set up in Prague (2007 G.A.) to prepare a reply to EMEA • All delegations were invited to give their comments and contributionscomments and contributions • An official EIPG document was submittedAn official EIPG document was submitted to EMEA on September 2007
  • 10. EIPG Working Groupg p Innovative Issues • promotion of quality risk management i i lprinciples • increase of QP discretion power and• increase of QP discretion power and extension of responsibilities • benefit in time response and in flexibility from Regulatory Bodiesfrom Regulatory Bodies
  • 11. EIPG Working Groupg p Critical Issues • a cultural change is required for the i l t ti f QRM i i limplementation of QRM principles • reducing level of details in MA seemsreducing level of details in MA seems difficult to be applied to existing dossiers • more flexible approach is required for dealing with recurrent deviationsdealing with recurrent deviations
  • 12. EIPG Working GroupEIPG Working Group Key PointsKey Points • incorporation into EU GMPsp (Annex 16 and other sections of GMPs) • QP responsibilities and duties• QP responsibilities and duties • QP reliance on the quality system • extension of the principles to IMPs
  • 13. Comments of Interested Parties Meeting held in London on 26 Sept 2007 with: APIC/CEFICAPIC/CEFIC EFPIA EGAEGA EIPG EQPA EVM IFAH-EU ISPEISPE PDA PPTAPPTA AESGP
  • 14. Comments of Interested Parties • Most of Interested Parties presentedMost of Interested Parties presented detailed comments and suggestions • EFPIA took the lead of the discussion • A common position was agreed A presentation as made to EMEA• A presentation was made to EMEA
  • 15. Comments of Interested Parties • Reflection Paper generally welcomedReflection Paper generally welcomed • Most companies not aware of the Reflection Paper • Proposal of EMEA not accepted byProposal of EMEA not accepted by Authorities in some Member States St t d i l l f d t il• Strong support on reducing level of details in MA dossiers
  • 16. Comments of Interested Parties QP discretion should be broadened to include: t d i tirecurrent deviations minor changes, pending approval of a filed variation OOS deviations for non critical attributes deviations from IMP dossier not impacting safety or efficacy
  • 17. Comments of Interested Parties • To extend the scope to any minor deviation (starting and packaging materials specs IPCs)(starting and packaging materials specs, IPCs), provided that safety and efficacy are met • To clarify that the QP involved in release of intermediate stage products may adopt the sameg p y p principles T l if th t it i t l t• To clarify that it is not always necessary to perform a formal risk assessment, but an i f l l i i t blinformal analysis is acceptable
  • 18. Comments of Interested Parties • The Reflection Paper is too limited as itThe Reflection Paper is too limited, as it does not allow for the full qualification and t bilit f th QP i b t h laccountability of the QP in batch release decision • Interested Parties ready to actively contrib te to re ision of Anne 16 andcontribute to revision of Annex 16 and GMPs to harmonise the QP role
  • 19. Comments of Interested Parties All comments presented to EMEAAll comments presented to EMEA Principles of the Reflection Paper accepted by all Member States Harmonisation on QP role expectedHarmonisation on QP role expected Agreement on the Annex 16 revision Further discussion required before implementationp
  • 20. Conclusions 1. EIPG was officially recognised among the1. EIPG was officially recognised among the European professional bodies 2. Broadening of QP discretion power is the key issue for the next futurey 3. QP qualification and professional development is part of EIPG strategic plan